Developer docs
API playgroundTry for free, no card

Search company profiles

Waveguide

Full company profile

uuid00029dr

Namestring
Waveguide
Legal namestring
WaveGuide Corporation
Company typeenum
Private
Founded yearint
2015
Descriptiontext

WaveGuide Corporation is a Waltham, Massachusetts-based medical and industrial diagnostic device company founded in 2015 by Dr. Marcus Semones around portable nuclear magnetic resonance technology licensed exclusively from Harvard University. The company's flagship product, the WaveGuide Formµla™, is marketed as the world's first battery-operated portable micro-nuclear magnetic resonance (μNMR) instrument, bringing laboratory-grade NMR analytical sensitivity and specificity to field environments without requiring PhD operators, fixed infrastructure, or large sample volumes. The platform combines proprietary magnetic nanoparticles for selective analyte binding with embedded WiFi and cellular connectivity (enabled by an AT&T partnership announced in 2018) for real-time data transmission.

The device is deployed across pharmaceutical quality control (anti-counterfeit screening, biosimilar authentication, stability studies, vaccine potency), medical diagnostics (tuberculosis and ovarian cancer screening under active FDA 510(k) pathways), food and beverage authenticity testing (dairy, olive oil, lubricants), and industrial fluid and equipment health monitoring. WaveGuide offers GMP and 21 CFR Part 11 compliant configurations, holds ISO 13485:2016 medical device manufacturer certification, and lists FDA certifications FM-672330 and MD-687233 (both running into 2027). The company has demonstrated quantifiable outcomes including TB detection at ~90% overall accuracy in sputum, contaminant detection in cough syrup at 2.5% concentration, and antibody concentration variation detection below 2 mg/mL.

WaveGuide sells exclusively through a direct enterprise sales motion (no self-serve or channel partners), reaching pharmaceutical manufacturers, medical facilities, food safety inspectors, and industrial operators via website contact, phone ((617) 892-9700), and email (biz@waveguidecorp.com). The company has raised over $30 million cumulatively across multiple SEC exempt securities offerings between 2015 and 2025, and operates with a lean leadership team of seven senior individuals plus a six-person board of directors and a scientific and advisory board.

Short descriptiontext

WaveGuide Corporation develops the WaveGuide Formµla™, the world's first battery-operated portable micro-nuclear magnetic resonance (μNMR) instrument, serving pharmaceutical manufacturers, medical facilities, food safety inspectors, and industrial operators with on-site chemical and biological diagnostics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWaltham, United States
HQ citystring
Waltham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
portable NMR devices, medical diagnostics, pharmaceutical quality control, food authenticity testing, industrial fluid analysis
Industry1 code
PRIMARYHLAGADAK
Material Characterization & Spectroscopy (NMR/FTIR/MS)
NAICS code1 code
  • Analytical Laboratory Instrument Manufacturing334516
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Analytical Instrumentation & Diagnostic Devices
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Portable NMR Hardware Sales
TypeHardware Sales
Description

WaveGuide sells its WaveGuide Formµla™ portable NMR device as a hardware product to enterprise customers across pharma, medical, food safety, and industrial sectors. Device configurations include GMP and 21 CFR Part 11 compliance variants.

waveguidecorp.com
2Customizable App Licensing / Software
TypeLicensing Royalties
Description

The WaveGuide Formµla™ platform supports multiple customizable apps for specific testing applications (purity, potency, authenticity). Apps can be tailored to specific industries and use cases (pharmaceuticals, food, oil & gas, medical diagnostics), suggesting a software/app licensing or configurable module model atop the hardware platform.

waveguidecorp.com
3Professional Services & Regulatory Support
TypeProfessional Services
Description

Wendy Graham-Coco, COO, oversees clinical, regulatory, and quality systems operations, and the company maintains ISO 13485:2016 medical device manufacturer certification. The company supports FDA 510(k) pathways for tuberculosis and ovarian cancer screening diagnostics, suggesting revenue from regulatory consulting and certification-related professional services.

waveguidecorp.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Others, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise direct sale — pricing available upon inquiry
ModelOtherBilling cadenceMulti-year contract
Notes

WaveGuide Formµla™ is sold directly to enterprise customers. No public price list is published. The company states the device costs significantly less than traditional NMR systems and requires only micro-liters of sample, reducing per-test consumables cost.

waveguidecorp.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1WaveGuide Formµla™
Description

The world's first portable battery-operated NMR device that detects and quantifies substances for medical, material and diagnostic applications.

waveguidecorp.com
Core offering1 text field

WaveGuide Corporation develops, manufactures and sells the WaveGuide Formµla™ — the world's first battery-operated portable micro-nuclear magnetic resonance (μNMR) instrument. The device enables on-site chemical and biological analysis without laboratory infrastructure, using proprietary magnetic nanoparticles to detect and quantify target analytes for medical diagnostics, pharmaceutical quality control, food safety, and industrial fluid monitoring. The platform supports configurable apps for purity, potency, authenticity, pathogen, and oncology testing, with available GMP and 21 CFR Part 11 compliance configurations for regulated environments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • TB detection with ~90% overall accuracy and ~85% sample accuracy, with detection in 1–3 hours in sputum using the WaveGuide Formµla™ prototype
+4 more records
Product overview1 text field

WaveGuide Corporation offers a single unified product—the WaveGuide Formµla™—the world's first battery-powered portable micro-nuclear magnetic resonance (μNMR) device. This compact analytical instrument brings laboratory-grade NMR spectroscopy to the field, enabling on-site detection and quantification of substances for medical diagnostics, pharmaceutical quality control, food safety testing, and industrial applications. The device requires no special training, operates on battery power, and includes embedded WiFi and cellular connectivity with a secure cloud-based environment for data tracking and analysis.

Product and service1 record
1WaveGuide Formµla™ Portable μNMR Instrument
CategoryAnalytical Instrumentation & Diagnostic Devices
Description

The world's first battery-operated portable micro-nuclear magnetic resonance (μNMR) instrument. Detects and quantifies substances for medical diagnostics (TB, ovarian cancer, pathogens), pharmaceutical quality control (anti-counterfeit, biosimilars authentication, vaccine potency, stability studies), food safety (purity, authenticity, fat/oil/moisture) and industrial maintenance (lubricant quality, wear monitoring). Operates on battery power with embedded WiFi/cellular connectivity for real-time cloud data transmission. Supports configurable apps by sample type and includes GMP and 21 CFR Part 11 compliant configurations. Requires only micro-liter samples and no specialized training; delivers results in minutes.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2018-02-22
Description

AT&T provides global cellular connectivity for the WaveGuide Formµla™ portable NMR device, enabling real-time secure data transmission from deployed field devices back to the company for analysis and outbreak tracking. The partnership was featured at Mobile World Congress 2018 (#MWC18) where AT&T Business showcased the WaveGuide device to a global audience. AT&T's Business news and Cheddar News have covered WaveGuide, providing significant third-party marketing credibility.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2015-01-01
Description

WaveGuide secured an exclusive license from the Technology Licensing Office of Harvard University for the portable NMR technology across multiple fields of use including medical diagnostics, pharmaceutical, food, oil & gas, THC/cannabis, and roadside detection. The underlying scientific breakthrough was pioneered by founder Dr. Marcus Semones during his faculty appointment at Harvard University's Physics Department. This exclusive license is the foundational IP moat for the entire WaveGuide business.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Nanalysis manufactures benchtop 60 MHz NMR spectrometers (NMReady series) for industrial QC, academic, and teaching use. It is the closest direct competitor in compact NMR form factor and serves overlapping pharma and chemistry end markets.

TypeDirect peer
Description

Magritek develops compact benchtop TD-NMR and NMR systems (Spinsolve family) used for chemistry education, reaction monitoring, and industrial QC. It competes directly with WaveGuide in the portable/benchtop TD-NMR category.

TypeDirect peer
Description

Oxford Instruments' MQC series of benchtop TD-NMR analyzers is widely used in food, agriculture, and industrial fluid analysis — overlapping heavily with WaveGuide's industrial and food-safety verticals in a portable form factor.

TypeEmerging player
Description

T2 Biosystems applies magnetic resonance (T2MR) to rapid in-vitro diagnostics for sepsis and other infectious diseases. It uses MR as a diagnostic platform like WaveGuide, though in a centralized instrument format rather than portable.

TypeBroad incumbent
Description

Bruker is the global leader in high-field NMR instrumentation and also offers benchtop/personal NMR (incl. former PicoSpin). It is the dominant incumbent WaveGuide must displace in pharma QC and academic NMR markets.

6JEOL
TypeBroad incumbent
Description

JEOL manufactures NMR spectrometers across high-field and benchtop segments (JNM-ECZ series) used in pharma, chemistry, and materials research. It is a broad incumbent in laboratory NMR alongside Bruker.

TypeBroad incumbent
Description

Thermo Fisher is the largest analytical instruments and life-sciences tools company, offering benchtop NMR, handheld spectroscopy (via Ahura Scientific acquisition), pharma QC, and clinical diagnostics platforms that overlap with multiple WaveGuide verticals.

TypeBroad incumbent
Description

Agilent provides a broad portfolio of analytical instruments (NMR, FTIR, mass spec) and pharma/biopharma QC solutions. It competes in the same regulated QC workflows WaveGuide targets, though typically with lab-bound instruments.

TypeOthers
Description

MKS acquired Precisive, a developer of compact gas-phase optical analyzers for oil & gas and industrial process monitoring. It is an adjacent, portable-analytical-instrument peer with overlap in industrial fluid and process analysis.

TypeEmerging player
Description

bioMérieux's BioFire business delivers rapid molecular diagnostics (FilmArray panels) for infectious disease at the point of care. It overlaps with WaveGuide's TB and infectious-disease field-diagnostic ambitions, albeit with a different (PCR) underlying technology.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Waveguide

Analytical Instrumentation & Diagnostic Deviceswaveguidecorp.com

WaveGuide Corporation develops the WaveGuide Formµla™, the world's first battery-operated portable micro-nuclear magnetic resonance (μNMR) instrument, serving pharmaceutical manufacturers, medical facilities, food safety inspectors, and industrial operators with on-site chemical and biological diagnostics.

What Waveguide does

WaveGuide Corporation is a Waltham, Massachusetts-based medical and industrial diagnostic device company founded in 2015 by Dr. Marcus Semones around portable nuclear magnetic resonance technology licensed exclusively from Harvard University. The company's flagship product, the WaveGuide Formµla™, is marketed as the world's first battery-operated portable micro-nuclear magnetic resonance (μNMR) instrument, bringing laboratory-grade NMR analytical sensitivity and specificity to field environments without requiring PhD operators, fixed infrastructure, or large sample volumes. The platform combines proprietary magnetic nanoparticles for selective analyte binding with embedded WiFi and cellular connectivity (enabled by an AT&T partnership announced in 2018) for real-time data transmission.

The device is deployed across pharmaceutical quality control (anti-counterfeit screening, biosimilar authentication, stability studies, vaccine potency), medical diagnostics (tuberculosis and ovarian cancer screening under active FDA 510(k) pathways), food and beverage authenticity testing (dairy, olive oil, lubricants), and industrial fluid and equipment health monitoring. WaveGuide offers GMP and 21 CFR Part 11 compliant configurations, holds ISO 13485:2016 medical device manufacturer certification, and lists FDA certifications FM-672330 and MD-687233 (both running into 2027). The company has demonstrated quantifiable outcomes including TB detection at ~90% overall accuracy in sputum, contaminant detection in cough syrup at 2.5% concentration, and antibody concentration variation detection below 2 mg/mL.

WaveGuide sells exclusively through a direct enterprise sales motion (no self-serve or channel partners), reaching pharmaceutical manufacturers, medical facilities, food safety inspectors, and industrial operators via website contact, phone ((617) 892-9700), and email (biz@waveguidecorp.com). The company has raised over $30 million cumulatively across multiple SEC exempt securities offerings between 2015 and 2025, and operates with a lean leadership team of seven senior individuals plus a six-person board of directors and a scientific and advisory board.

Waveguide firmographics

Firmographics
Name
Waveguide
Legal name
WaveGuide Corporation
Website
https://waveguidecorp.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
WaveGuide Corporation develops the WaveGuide Formµla™, the world's first battery-operated portable micro-nuclear magnetic resonance (μNMR) instrument, serving pharmaceutical manufacturers, medical facilities, food safety inspectors, and industrial operators with on-site chemical and biological diagnostics.
Ownership category
akta.pro rank

Waveguide industry classification

Industry
Product category
Analytical Instrumentation & Diagnostic Devices
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGADAK
Material Characterization & Spectroscopy (NMR/FTIR/MS)

Keywords

  • Portable NMR devices
  • Medical diagnostics
  • Pharmaceutical quality control
  • Food authenticity testing
  • Industrial fluid analysis

Where Waveguide is headquartered

Location

Headquarters

HQ city
Waltham
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Waveguide business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Others, Marketing or Sales, Infrastructure

Revenue model

  1. Portable NMR Hardware Sales: WaveGuide sells its WaveGuide Formµla™ portable NMR device as a hardware product to enterprise customers across pharma, medical, food safety, and industrial sectors. Device configurations include GMP and 21 CFR Part 11 compliance variants.
  2. Customizable App Licensing / Software: The WaveGuide Formµla™ platform supports multiple customizable apps for specific testing applications (purity, potency, authenticity). Apps can be tailored to specific industries and use cases (pharmaceuticals, food, oil & gas, medical diagnostics), suggesting a software/app licensing or configurable module model atop the hardware platform.
  3. Professional Services & Regulatory Support: Wendy Graham-Coco, COO, oversees clinical, regulatory, and quality systems operations, and the company maintains ISO 13485:2016 medical device manufacturer certification. The company supports FDA 510(k) pathways for tuberculosis and ovarian cancer screening diagnostics, suggesting revenue from regulatory consulting and certification-related professional services.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise direct sale — pricing available upon inquiry

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Waveguide product offering

Product offering

Core offering

WaveGuide Corporation develops, manufactures and sells the WaveGuide Formµla™ — the world's first battery-operated portable micro-nuclear magnetic resonance (μNMR) instrument. The device enables on-site chemical and biological analysis without laboratory infrastructure, using proprietary magnetic nanoparticles to detect and quantify target analytes for medical diagnostics, pharmaceutical quality control, food safety, and industrial fluid monitoring. The platform supports configurable apps for purity, potency, authenticity, pathogen, and oncology testing, with available GMP and 21 CFR Part 11 compliance configurations for regulated environments.

Product overview

WaveGuide Corporation offers a single unified product—the WaveGuide Formµla™—the world's first battery-powered portable micro-nuclear magnetic resonance (μNMR) device. This compact analytical instrument brings laboratory-grade NMR spectroscopy to the field, enabling on-site detection and quantification of substances for medical diagnostics, pharmaceutical quality control, food safety testing, and industrial applications. The device requires no special training, operates on battery power, and includes embedded WiFi and cellular connectivity with a secure cloud-based environment for data tracking and analysis.

Differentiator

Problem solved

Functional benefit

Brands

  • WaveGuide Formµla™: The world's first portable battery-operated NMR device that detects and quantifies substances for medical, material and diagnostic applications.

Products and services

  • WaveGuide Formµla™ Portable μNMR Instrument The world's first battery-operated portable micro-nuclear magnetic resonance (μNMR) instrument. Detects and quantifies substances for medical diagnostics (TB, ovarian cancer, pathogens), pharmaceutical quality control (anti-counterfeit, biosimilars authentication, vaccine potency, stability studies), food safety (purity, authenticity, fat/oil/moisture) and industrial maintenance (lubricant quality, wear monitoring). Operates on battery power with embedded WiFi/cellular connectivity for real-time cloud data transmission. Supports configurable apps by sample type and includes GMP and 21 CFR Part 11 compliant configurations. Requires only micro-liter samples and no specialized training; delivers results in minutes.

Quantifiable outcome

  • TB detection with ~90% overall accuracy and ~85% sample accuracy, with detection in 1–3 hours in sputum using the WaveGuide Formµla™ prototype
  • +4 more outcomes

Companies that use Waveguide

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Waveguide technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature6 records

Waveguide partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • AT&TcoreGTM or Marketing Partner · 22 February 2018AT&T provides global cellular connectivity for the WaveGuide Formµla™ portable NMR device, enabling real-time secure data transmission from deployed field devices back to the company for analysis and outbreak tracking. The partnership was featured at Mobile World Congress 2018 (#MWC18) where AT&T Business showcased the WaveGuide device to a global audience. AT&T's Business news and Cheddar News have covered WaveGuide, providing significant third-party marketing credibility.
  • Harvard University (Technology Licensing Office)coreTechnology or Integration · 1 January 2015WaveGuide secured an exclusive license from the Technology Licensing Office of Harvard University for the portable NMR technology across multiple fields of use including medical diagnostics, pharmaceutical, food, oil & gas, THC/cannabis, and roadside detection. The underlying scientific breakthrough was pioneered by founder Dr. Marcus Semones during his faculty appointment at Harvard University's Physics Department. This exclusive license is the foundational IP moat for the entire WaveGuide business.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Waveguide competitors and assessment

Company assessment

Direct peers

  • Nanalysis: Nanalysis manufactures benchtop 60 MHz NMR spectrometers (NMReady series) for industrial QC, academic, and teaching use. It is the closest direct competitor in compact NMR form factor and serves overlapping pharma and chemistry end markets.
  • Magritek: Magritek develops compact benchtop TD-NMR and NMR systems (Spinsolve family) used for chemistry education, reaction monitoring, and industrial QC. It competes directly with WaveGuide in the portable/benchtop TD-NMR category.
  • Oxford Instruments (Magnetic Resonance): Oxford Instruments' MQC series of benchtop TD-NMR analyzers is widely used in food, agriculture, and industrial fluid analysis — overlapping heavily with WaveGuide's industrial and food-safety verticals in a portable form factor.

Emerging players

  • T2 Biosystems: T2 Biosystems applies magnetic resonance (T2MR) to rapid in-vitro diagnostics for sepsis and other infectious diseases. It uses MR as a diagnostic platform like WaveGuide, though in a centralized instrument format rather than portable.
  • bioMérieux (BioFire): bioMérieux's BioFire business delivers rapid molecular diagnostics (FilmArray panels) for infectious disease at the point of care. It overlaps with WaveGuide's TB and infectious-disease field-diagnostic ambitions, albeit with a different (PCR) underlying technology.

Broad incumbents

  • Bruker Corporation: Bruker is the global leader in high-field NMR instrumentation and also offers benchtop/personal NMR (incl. former PicoSpin). It is the dominant incumbent WaveGuide must displace in pharma QC and academic NMR markets.
  • JEOL: JEOL manufactures NMR spectrometers across high-field and benchtop segments (JNM-ECZ series) used in pharma, chemistry, and materials research. It is a broad incumbent in laboratory NMR alongside Bruker.
  • Thermo Fisher Scientific: Thermo Fisher is the largest analytical instruments and life-sciences tools company, offering benchtop NMR, handheld spectroscopy (via Ahura Scientific acquisition), pharma QC, and clinical diagnostics platforms that overlap with multiple WaveGuide verticals.
  • Agilent Technologies: Agilent provides a broad portfolio of analytical instruments (NMR, FTIR, mass spec) and pharma/biopharma QC solutions. It competes in the same regulated QC workflows WaveGuide targets, though typically with lab-bound instruments.

Others

  • MKS Instruments (Precisive): MKS acquired Precisive, a developer of compact gas-phase optical analyzers for oil & gas and industrial process monitoring. It is an adjacent, portable-analytical-instrument peer with overlap in industrial fluid and process analysis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Waveguide social profiles

Digital presence

Waveguide compliance and trust

Trust signal

Compliance5 records

Waveguide financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Waveguide leadership team

Management profile

Number of profiles

Profiles7 records

Waveguide funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Waveguide M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Waveguide

What does Waveguide do?

WaveGuide Corporation develops, manufactures and sells the WaveGuide Formµla™ — the world's first battery-operated portable micro-nuclear magnetic resonance (μNMR) instrument. The device enables on-site chemical and biological analysis without laboratory infrastructure, using proprietary magnetic nanoparticles to detect and quantify target analytes for medical diagnostics, pharmaceutical quality control, food safety, and industrial fluid monitoring. The platform supports configurable apps for purity, potency, authenticity, pathogen, and oncology testing, with available GMP and 21 CFR Part 11 compliance configurations for regulated environments.

Is Waveguide a public or private company?

Waveguide is a private company. It is classified as venture growth investor backed and is currently operating.

When was Waveguide founded?

Waveguide was founded in 2015. It employs 11 to 50 people.

Where is Waveguide based?

Waveguide is headquartered in Waltham, United States, in the North America region.

How does Waveguide make money?

Three revenue lines are on record. Portable NMR Hardware Sales are the primary driver. The others are customizable App Licensing / Software and professional Services & Regulatory Support.

Who are Waveguide's main competitors?

Direct peers on record are Nanalysis, Magritek and Oxford Instruments (Magnetic Resonance). Emerging players are T2 Biosystems and bioMérieux (BioFire). Broad incumbents are Bruker Corporation, JEOL, Thermo Fisher Scientific and Agilent Technologies. MKS Instruments (Precisive) is listed as an others.

Does Waveguide have an API?

No public API is recorded for Waveguide.

What industry is Waveguide in?

Waveguide's product category is Analytical Instrumentation & Diagnostic Devices. Its primary akta.pro industry code is HLAGADAK, Material Characterization & Spectroscopy (NMR/FTIR/MS). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SecSEC FORM DThe article reports on the SEC filing by WaveGuide Corp for an exempt securities offering, including details about the company's size, industry, and the total amount of securities offered. The filing indicates the company is based in Waltham, Massachusetts, with an offering amount of $6,500,000 and a current sale amount of $2,999,908.SecSEC FORM DWaveGuide Corp filed a Form D with the SEC on May 8, 2024, for an exempt offering of securities under Rules 504 and 506(b). The company has raised $1,858,685 out of a total offering amount of $4,300,000 from 26 investors as of the filing date.PrwebFairview Microwave Releases New Double Ridge Waveguide Switches Supporting Broadband Frequencies up to 40 GHzFairview Microwave introduced a new series of double ridge waveguide electromechanical relay switches covering 6.5 to 40 GHz. The 12-model line offers 80 dB isolation, 2.5 dB insertion loss, and 8.5 kW power handling, with no minimum order quantity and immediate shipping.PR NewswireThe Power of Connected Health on Display at Mobile World CongressAT&T is showcasing connected health devices powered by its IoT technology at Mobile World Congress in Barcelona, featuring solutions from partners WaveGuide, swyMed, and Softbox. These technologies aim to improve healthcare delivery through rapid disease monitoring, remote telemedicine, and smart medication tracking using AT&T's global connectivity. The demonstration highlights how IoT enables quicker diagnoses, expert care access in remote areas, and better management of temperature-sensitive medications.